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ABSTRACT
Recent studies indicate that controlling the nuclear
decondensation and intra-nuclear localization of
plasmid DNA (pDNA) would result in an increased
transfection efficiency. In the present study, we
established a technology for imaging the nuclear
condensation/decondensation status of pDNA in
nuclear subdomains using fluorescence resonance
energy transfer (FRET) between quantum dot (QD)-
labeled pDNA as donor, and rhodamine-labeled
polycations as acceptor. The FRET-occurring
pDNA/polycation particle was encapsulated in a
nuclear delivery system; a tetra-lamellar multifunc-
tional envelope-type nano device (T-MEND),
designed to overcome the endosomal membrane
and nuclear membrane via step-wise fusion.
Nuclear subdomains (i.e. heterochromatin and eu-
chromatin) were distinguished by Hoechst33342
staining. Thereafter, Z-series of confocal images
were captured by confocal laser scanning micros-
copy. pDNA in condensation/decondensation status
in heterochromatin or euchromatin were quantified
based on the pixel area of the signals derived from
the QD and rhodamine. The results obtained
indicate that modulation of the supra-molecular
structure of polyrotaxane (DMAE-ss-PRX), a con-
denser that is cleaved in a reductive environment,
conferred euchromatin-preferred decondensation.
This represents the first demonstration of the
successful control of condensation/decondensation
in specific nuclear sub-domain via the use of an arti-
ficial DNA condenser.
INTRODUCTION
In post-genome era, gene therapy is one of the new-
generation approaches for the cure of intractable
diseases, which can complement the defective gene (1–3).
Since viral gene carrier potentially has adverse effects such
as oncogenicity (4) and inﬂammation (5), efﬁcient
non-viral carrier is highly desired. It is generally con-
sidered that transfection activity is rate limited by a
variety of intracellular process such as endosomal escape
and nuclear transfer (6). Recent quantitative comparison
of intracellular trafﬁcking of plasmid DNA (pDNA) and
adenovirus collectively revealed that post-nuclear delivery
processes (i.e. transcription and translation) are dominant
rate-limiting processes for the 2- or 3-order of magnitude
less transfection efﬁciency in non-viral vectors (7–9).
Further mechanism-based studies clariﬁed that pDNA
transfected with lipoplex mainly exist as condensed form
in the nucleus, which prevents it from the access to tran-
scription factors (7). In contrast, adenovirus genomic
DNA is efﬁciently released in the nucleus. Moreover,
adenoviral genome DNA was speciﬁcally localized on
the euchromatin region (7), where transcription activity
is relatively active (10–13).
Herein, we established an imaging technology for
visualizing and quantifying nuclear decondensation in
speciﬁed nuclear sub-domains by means of ﬂuorescence
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(QDs)-labeled pDNA as a donor, and rhodamine-labeled
polycation as an acceptor.
FRET is a promising technique for monitoring
decondensation processes in cells, that occurs between
donor–acceptor dyes tagged on single DNA molecules
(14), or between dyes separately tagged on pDNA and a
carrier (15,16). Of note, an analysis of FRET in the
nucleus indicated that pDNA transfected with linear
polyethylenimine or histidylated polylysine are present in
the nucleus in a condensed form (15). To explain gene
expression in terms of intranuclear disposition, quantiﬁca-
tion of the condensation/decondensation status in more
speciﬁed intranuclear regions is required. In the present
study, we established a technique for quantifying pDNA
in a condensed or decondensed form in heterochromatin
and euchromatin. In this system, we used QD as a donor,
since it has been successfully used as a probe for the
analysis of intracellular trafﬁcking of macromolecules,
including DNA in the past (17,18). Although CdSe-QD
has some cytotoxicity due to the release of cadmium ions
under UV-radiation (19), ﬂuorescent CdSe/ZnS
nanocrystals have been reported to be ideal for the use
in long-term, non-toxic imaging of nuclear targeting in
living cells (20), since they show superior brightness and
resistance to photobleaching, compared to organic
ﬂuorophores. These unique characteristics facilitate the
identiﬁcation of the nuclear localization of pDNA and
avoid the risks associated with loss of DNA-derived
signals by repeated excitation when Z-stack images are
obtained. It is also noteworthy that the emission spectra
of QDs can be easily modulated by changing the size of
the QD, thus permitting spectral overlap to be optimized
(21). The quantiﬁcation of intracellular and intra-nuclear
decondensation by monitoring FRET QD-labeled pDNA
and acceptor-labeled polycations has been reported previ-
ously (22). In the present study, we advanced this ana-
lysis by one-step further, characterizing the nuclear
sub-domain to which the DNA was routed.
For an evaluation of the nuclear dispositions in relation
to the transgene expression, efﬁcient nuclear delivery
system is prerequisite. For this purpose, a pDNA/
polycation core was encapsulated in multilayered lipid
envelope-type nanoparticle was used, which we refer to
as a tetra-lamellar multi-functional envelope-type nano
device (T-MEND) (23). In this system, condensed DNA
cores are coated with two nuclear membrane-fusogenic
inner envelopes and two endosome-fusogenic outer
envelopes, both of which are designed to overcome
the endosomal membrane and nuclear membranes,
respectively.
Using the present method, we were able to demonstrate
the ﬁrst successful control of a condensation/
decondensation proﬁle in the intra-nuclear sub-domain
using a synthetic polycation, polyrotaxane (PRX), which
possessed a necklace-like structure composed of
dimethylaminoethyl-modiﬁed a-cyclodextrin; DMAE-a-
CD) and a disulﬁde-introduced PEG chain (15). To
render it bio-cleavable, the end of the PEG chain was
capped via disulﬁde bonding (Figure 1a). The ﬂexible
movement of a-CDs along with the PEG thread facilitates
electrostatic interactions between pDNA and PRX
multivalently by avoiding spatial mismatching (24).
Thus, the method is useful in investigating the mechanism
of extensive gene expression, and in understanding the
rate-limiting processes to be overcome for further
gene expression from the point of view of intra-nuclear
disposition.
MATERIALS AND METHODS
Materials
1.2-Dioleoyl sn-glycero-3-phosphatidylethanolamine
(DOPE) was purchased from Avanti Polar lipids
(Alabaster, AL, USA). Cardiolipin (CL) and phosphatidic
acid (PA) were purchased form Sigma (St Louis, MO,
USA). Protamine sulfate salmon mint was purchased
from Calbiochem (Darmstadt, Germany). Plasmid DNA
pCMV-luc encoding luciferase was prepared using an
EndoFree Plasmid Mega Kit (Qiagen, Germany). Stearyl
octaarginine (STR-R8) (25) and cholesteryl-GALA (26)
was custom-synthesized by NeoMPS (NeoMPS Inc., San
Diego, CA, USA). HeLa cells were obtained from the
RIKEN Cell Bank (Tsukuba, Japan) and Health Science
Research Resources Bank (Osaka, Japan), respectively. In
this study, we used luciferase (GL3)-inserted plasmid
DNA. To prepare the luciferase-encoding vector, an
insert fragment encoding luciferase (GL3) was obtained
by Hind III/Xba I digestion of the pGL3-basic vector
(Promega, Madison, WI, USA), and ligated to the
HindIII/Xba I digested site of pcDNA3.1 (Invitrogen,
Carlsbad, CA, USA) as reported previously (8,27).
QD-545 streptavidin was obtained from Invitrogen.
Preparation of polyplexes of pcDNA 3.1-luc and
polyrotaxanes
In order to prepare pDNA core particle with DMAE-
ss-PRX, 100ml of naked pDNA solution (0.1mg/mli n
10mM HEPES) was added to 100ml of polycation
solution as demonstrated previously (28). The concentra-
tion of the DMAE-ss-PRX (Cp) at charge ratios was
calculated using the following equation:
Charge ratio (  Þ¼f Cp   NDMAE=MWpg=ðCD=MWDÞ,
where, NDMAE denote the number of DMAE (16 in
16DMAE-ss-PRX and 46 in 46DMAE-ss-PRX) residues
in the polycation molecule. The charge ratio (±) denotes
the ratio of number of positive charges derived from
amino groups of DMAE-ss-PRX to that of negative
charges on phosphate groups of DNA. MWP and MWD
denote the molecular weight of the polycation
(16DMAE-ss-PRX: 24600, 46DMAE-ss-PRX:29200) and
one nucleotide (average: 308), respectively.
CD denotes the concentration of pDNA (0.1mg/ml). In
the present study, we prepared the condensed core at
charge ratio of 5. In this condition, a 2.4ml aliquot of
pDNA (2.5mg/ml) (0.1mg/ml ﬁnal concentration) was
mixed with a 9ml aliquot of 10mM of DMAE-units
DMAE-ss-PRX (ﬁnal concentration 1mM of DMAE
units). The diameter and zeta-potential of the T-MEND
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spectrophotometer (Zetasizer; Malvern Instruments Ltd,
Malvern, WR, UK). As a reference of gene transfection,
pDNA was also condensed with protamine at charge ratio
of 2.2 as described previously (27).
Preparation of T-MEND
Lipid ﬁlms composed of DOPE/CL=5:5 (total lipid
content: 0.55mmol) were hydrated with 1ml of 10mM
HEPES buffer (pH 7.4) for 10min at room temperature.
The hydrated lipid ﬁlm was then sonicated using a
probe-type sonicator (BRANSON Digital Soniﬁer-250;
Danbury, CT, USA) with an amplitude of 25% for
10min to form single unilamellar vesicles (SUVs1).
Similarly, SUVs was prepared with DOPE with
phosphatidic acid (PA) of 7:2 ratio (total lipid content:
0.55mmol) and additional 1% mol of cholesterol-
modiﬁed GALA peptide (SUVs2). Condensed DNA par-
ticles prepared above were mixed with SUVs1 at a ratio of
2:1 (v/v) to coat the condensed DNA particles with a
double-lipid envelope as described previously (29,30). A
stearylated octaarginine (STR-R8) solution (20% mol of
total lipid) was added to the suspension of double-layered
nuclear membrane-fusogenic particles. Then, this suspen-
sion of nuclear membrane-fusogenic particles was mixed
(a)
(b)( c)
Figure 1. Schematic diagram illustrating technologies for intracellular trafﬁcking and programed decondensation. (a) Structure of DMAE-ss-PRX
and rhodamine-labeled DMAE-ss-PRX. It has an orientation, which resembles to a necklace-like structure composed of dimethylaminoethyl-
modiﬁed a-cyclodextrin; DMAE-a-CD and a disulﬁde-introduced PEG chain. Moreover, the end of the PEG chain was capped via disulﬁde
bonding. The number of threaded a-CDs and the molecular weight of PEG in the polyrotaxanes were 18 and 4000, respectively. (b) The strategy
to deliver pDNA to the nucleus via a series of membrane fusions using T-MEND. pDNA is condensed with a polycation and then coated with a
nucleus-fusogenic lipid membrane (inner) and an endosome-fusogenic lipid membrane (outer). The surface is modiﬁed with a high density of
octaarginine (R8), which marks the liposomes for internalization into cells via macropinocytosis (40). During stepwise fusion, the pDNA/polycation
core is released from the lipid envelope, which is advantageous for efﬁcient transcription. (c) Transfection activity of T-MENDs encapsulating pDNA
core particles formed with DMAE-ss-PRXs and protamine. HeLa cells were transfected with T-MENDs containing luciferase-encoding pDNA for
24h. And thereafter transgene expression (luciferase activity) was performed as described in ‘Materials and Methods’ section.
PAGE 3 OF 12 Nucleic AcidsResearch, 2011, Vol.39,No. 7 e48with endosome-fusogenic SUVs2 at a ratio of 1:2 (v/v) to
generate particles with a double endosome-fusogenic
envelope, which we refer to as T-MEND. Stearylated
octaarginine (STR-R8) solution (10% mol of
endosome-fusogenic lipid) was added to the suspension
of T-MEND to modify the outer envelope with R8.
Transfection studies
HeLa were maintained in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% fetal bovine
serum at 37 C under an atmosphere with 5% CO2. Cells
were seeded onto 24-well plates at a density of 4 10
4 cells
per well for 48h. A 100ml aliquot of T-MEND containing
0.4mg DNA in serum-free DMEM (1.9ml) was applied,
and incubated for 3h. Then, the culture media were
replaced with a fresh medium containing a 6% serum,
and additionally incubated for 21h. For a luciferase
assay, cells were washed with 0.5ml of phosphate-buffered
saline (PBS; pH 7.4). Reporter lysis buffer (0.2ml) was
then added to each well to lyse the cells. The cell suspen-
sion was next frozen by placing them in an  80 C freezer
for 30min, and thawed, followed by centrifugation at 15
000rpm for 2min. The relative light units (RLU) were
measured using a luminometer (Bio-instrument ATTO
Luminescencer AB-2200, Japan), and normalized to the
protein content using the bicinchoninic acid (BCA)
protein assay (Bio-Rad).
FRET optimization
pDNA was labeled with a Mirus Label IT CX-biotin
nucleic acid labeling kit (Mirus Corp., Madison, WI,
USA) with minor modiﬁcations. Shortly, the pDNA was
labeled in optimized buffer supplied in the kit, but the
Label IT solution was mixed at a 1/10 concentration of
the manufacturer’s recommended protocol of a Mirus
Label IT CX-biotin nucleic acid labeling kit, by prelim-
inarily diluting the solution with distilled water. pDNA
was incubated for 60min, and then biotin labeled
pDNA was puriﬁed by ethanol precipitation. The concen-
tration of biotin labeled pDNA was adjusted to 0.2mg/ml
(0.05mM ﬁnal), and then a 50ml aliquot of the solution
was incubated with a 10ml aliquot of the QD-545
streptavidin (0.02mM ﬁnal concentration) in HEPES
(pH 7.4) buffer at room temperature for at least 30min.
After QD labeling, the excess QD was puriﬁed from the
labeled DNA by passing through the Sephadex G50 mini
column, which is equilibrated with distilled water. FRET
was optimized by partially replacing a 16DMAE-ss-PRX
and 46DMAE-ss-PRX with rhodamine-DMAE-ss-PRX.
The synthesis of rhodamine-DMAE-ss-PRX was
described in Supplementary Data. Keeping a charge
ratio constant at 5, ﬂuorescence was measured in a real
time ﬂuorescence photometer (JASCO, FP-750 spectro-
ﬂurometer, Tokyo, Japan), where the QDs were excited
at 340nm and an emission spectrum was collected from
550 to 650nm.
Confocal image studies
For confocal image studies 5 10
4 cells/well were seeded
on 35-mm glass base dishes (IWAKI, Tokyo, Japan) for 2
days, and then transfected with T-MEND containing
0.4mg of QD-labeled DNA condensed with acceptor-
labeled DMAE-ss-PRX at 37 C under an atmosphere
with 5% CO2. At 3h after transfection, medium was
changed with fresh culture medium, and then incubated
for additional 3h. The nuclei were then stained with
1mg/ml of Hoechst 33342, 15min before observation.
Cells were washed with 5mM HEPES containing
20U/ml of heparin sodium to remove the T-MEND
bound on the cell-surface. Thereafter, medium was
replaced with HEPES buffer (135mM NaCl, 5.4mM
KCl, 1.0mM MgCl2, 1.8mM CaCl2, 5mM HEPES and
10mM glucose; pH=7.3), and examined by confocal
laser scanning microscopy (LSM 510 META; Carl Zeiss
Co. Ltd, Jena, Germany) equipped with an oil-immersion
objective lens (Plan-Apochromat 63 /NA=1.4). Nucleus
(Hoechst 33342) was excited by a 2-photon Maitai laser
(780nm). The QD was then excited by light (488nm) from
an argon laser. Imaging without the use of a UV laser is
advantageous, in that it avoids cytotoxic effects of QD in
response to the UV-radiation (19). The emitted light was
ﬁltered through a dichroic mirror (HFT488) and spectro-
photometrically analyzed using a spectrophotometric
detector (META) over a range of 530–630nm in 10nm
increments. Spectral data are presented as relative ﬂuores-
cence intensity compared to maximum intensity (545nm).
For capturing the images by spectral mode (  mode),
the QD was similarly excited by light (488nm) from an
argon laser. The emitted light ranging from 537 to 569nm,
and >630nm was simultaneously corrected by META
equipment for the QD-and rhodamine-derived signals.
These data were digitally exhibited in green (G) and red
(R) channels, respectively. Thereafter, the Hoechst33342
signals excited by a 2-photon Maitai laser (780nm) were
captured, and digitally exhibited in blue (B) channel. The
threshold for differentiating between heterochromatin and
euchromatin was determined based on the histogram of
the ﬂuorescence intensity in each pixel (x-axis) versus the
number of pixel areas (y-axis). In every region of interest
(r.o.i) surrounding a total nucleus, the histogram repre-
sented a single-peaked spectrum at a lower level of ﬂuor-
escence intensity. The pixels with higher intensities did not
exhibit any peak, since distribution of intensity in each
pixel is highly scattered. We denoted the highest tail of
the single-peaked spectrum as a threshold ﬂuorescent in-
tensity to separate the heterochromatin and euchromatin
regions.
Quantiﬁcation of pDNA by means of CIDIQ method
Intra-nuclear distribution and decondensation efﬁciency
of plasmid DNA in intra-nuclear region was quantiﬁed
by confocal image-assisted three-dimensionally integrated
quantiﬁcation (CIDIQ) method, which is originally de-
veloped to quantify the distribution of exogenous DNA
in endosome/lysosome, cytosol, and nucleus with sequen-
tial Z-series images captured by confocal laser scanning
microscopy (31). Z-series of images exported as 8-bit
TIFF-format image data were transferred to an
Image-Pro Plus software (Media Cybernetics Inc., Silver
Spring, MD, USA). All of Z-series of stack ﬁles were
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pixel area count, which satisfy the threshold pixel intensity
in each RGB images or arbitrary combination of RGB
channels in marked region of interest (r.o.i.). Digital
noise was ﬁltered out by avoiding single-pixel signals.
The counts in mock-treated cells (non-transfected cells)
were negligible in the calculation of pixel areas in the G
and R channels. Detail equation is listed in Supplementary
Data.
To determine the minimal number of cells required for
analysis, the statistical parameter of the coefﬁcient of vari-
ation (C.V.) was determined. When the C.V. values for the
fraction of pDNA in condensation and decondensation
status in euchromatin and heterochromatin (F
hetero
G,
F
hetero
Y, F
hetero
R, F
eu
G, F
eu
Y and F
eu
R) were plotted
against the number of the analyzed cells, all of the C.V.
values reached a plateau at 10 cells (Supplementary
Figure S1). Therefore, we concluded that 10 cells were
sufﬁcient to obtain reliable results.
RESULTS
Transgene expression transduced by T-MEND vector
containing pcDNA3.1-luciferase
Since decondensation kinetics in cells and nucleus are
altered depending on the pDNA condenser used (22), its
selection is one of the key determining factors for gene
expression efﬁciency. As the synthetic DNA condenser,
we selected biocleavable polyrotaxane (DMAE-ss-PRX)
in which cationic DMAE-a-CD units were linked
together with poly (ethylene glycol) (PEG) chains (MW;
3500–4500) in monliform, and capped with disulﬁde-
bonding (32,33) (Figure 1a). Two kinds of DMAE-ss-
PRX were used in the present analysis, in which 16 or
46-dimethylaminoethyl (DMAE) units were incorporated
in one molecule, in average. Here, we refer to as
16DMAE-ss-PRX and 46DMAE-ss-PRX, respectively.
The core formed with 16DMAE-ss-PRX represented rela-
tively higher size and polydispersity index (PDI) compared
with 46DMAE-ss-PRX and protamine (Table 1).
To deliver the pDNA/polycation core to the nucleus, we
used a T-MEND, the critical structural elements of which
(23) are a DNA–polycation condensed core coated with
two nuclear membrane-fusogenic inner envelopes and two
endosome-fusogenic outer envelopes. It is designed to
overcome the endosomal membrane and nuclear mem-
branes via stepwise fusion, through a ‘nuclear pore
complex (NPC)-independent pathway’ (Figure 1b). The
resulting T-MEND particles formed with 16DMAE-ss-
PRX had slightly larger diameters and PDI values
compared with those prepared using 46DMAE-ss-PRX,
but the z-potential was comparable for the two samples.
The size of the T-MEND prepared with protamine was
smaller, with a minimum PDI, and had a highly positive z-
potential (Table 1). As shown in Figure 1c, the transfec-
tion activity of the T-MEND prepared with
46DMAE-ss-PRX showed a signiﬁcantly higher gene ex-
pression compared with those prepared with 16DMAE-ss-
PRX. The mock treated cells (non-transfected cells)
showed negligible luciferase activity (<10
3 RLU/mg
protein). Of note, the Z-potential of the T-MEND
prepared with 46DMAE-ss-PRX was higher than a
T-MEND prepared with protamine, a natural DNA con-
denser. Thus, the stimulated transfection activity of the
T-MEND prepared with 46DMAE-ss-PRX cannot be
explained by enhanced cellular uptake. As shown in
Figure 1c, the transfection activity of T-MEND
prepared with 46DMAE-ss-PRX represented signiﬁcantly
higher gene expression compared with those prepared with
16DMAE-ss-PRX. It is unique demonstration showing an
impact of modulation of condenser on transfection
activity of T-MEND (23). In the following experiments,
we compared the intra-nuclear disposition of pDNA
condensed with 16DMAE-ss-PRX and 46DMAE-
ss-PRX.
Labeling of plasmid DNA and FRET optimization
For a labeling of pDNA with QD545, pDNA was ﬁrst
covalently labeled to biotin, followed by conjugation
with streptavidin-modiﬁed QD. In this labeling, we
incubated the QDs with biotin-labeled pDNA at a molar
ratio of 0.4 (QD; 0.02mM ﬁnal and DNA; 0.05mM ﬁnal)
to avoid a situation in which one pDNA possessed
multiple numbers of QDs. If the reaction proceeds stoi-
chiometrically, it would be expected that the pDNA would
contain 0 or 1 QDs per pDNA molecule. After conjuga-
tion with the QDs, QD-labeled pDNA was puriﬁed on a
Sephadex G50 mini column. Complete removal of free
streptavidin-labeled QD was conﬁrmed (Supplementary
Figure S2). QD-labeling of DNA was validated by 1%
agarose gel electrophoresis. As shown in Figure 2a, QD
conjugated with pDNA (lane ‘Pre’) proceeded through the
agarose gel more extensively compared with free QD (lane
‘Q’). Free QDs are slightly charged molecules, the charge
of which is derived from surface-modiﬁed streptavidin,
while pDNA is highly negatively charged due to phos-
phate groups. Thus, QD, when conjugated with pDNA,
developed extensively compared with free-form QDs by
electrophoresis, although the size of the QDs is smaller
than QD-conjugated pDNA. Moreover, the QD signals
(Figure 2a; lane ‘Pre’) were overlapped to the pDNA
signals which are appeared by staining with ethidium
bromide (Figure 2b; lane ‘Pre’). These ﬁndings also con-
ﬁrmed that QD-labeling did not occur in biotin-unlabeled
pDNA (Supplementary Figure S2). Collectively, these
Table 1. Dynamic light scattering studies of the core and R8
T-MEND, using Protamine, 16DMAE-ss-PRX and 46DMAE-ss-PRX
with pcDNA 3.1-luc
Name of packaging material Size
(nm)
Polydispersity
index (PDI)
Zeta-
potential
(mV)
Core Protamine 87–102 0.28–0.30 (+) 27–30
Core 16DMAE-ss-PRX 135–150 0.24–0.37 (+) 18–23
Core 46DMAE-ss-PRX 90–105 0.15–0.21 (+) 22–28
T-MEND (Protamine) 150–189 0.15–0.20 (+) 42–54
T-MEND (16DMAE-ss-PRX) 275–315 0.23–0.36 (+) 25–33
T-MEND (46DMAE-ss-PRX) 200–221 0.15–0.19 (+) 35–43
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avidin–biotin interactions. Compared with QD-unlabeled
pDNA, bands corresponding to labeled pDNA (lanes
‘Pre’ and ‘Pro’) were broader, probably because the
band includes QD-labeled and unlabeled pDNA, as
described above. It is noteworthy that free form of QD
was not detected after (lane ‘Pro’) and even before (lane
‘Pre’) the puriﬁcation of QD-labeled pDNA. These data
collectively suggested that QDs bound to the pDNA
stoichiometrically.
For FRET analysis, rhodamine-labeled PRXs were
partially replaced with non-labeled DMAE-ss-PRX
keeping a ﬁnal N/P ratio at 5 (Figure 3a). To minimize
a change in the condensation/decondensation proﬁle,
same length of the PEG chain (MW; 3500–4500) was
used. Each chain possessed one rhodamine unit in
average. Acceptor-labeled polyrotaxane (Rho-DMAE-
ss-PRX) was used as a portion of the condenser (5% of
its weight in 16DMAE-ss-PRX and 46DMAE-ss-PRX).
This conﬁrms that the ﬂuorescence of rhodamine labeled
on DMAE-ss-PRX is not affected when it is subjected to
condensation with QD (donor)-unlabeled pDNA, and
excited at 543nm, the optimum wave length for its exci-
tation. Thus, the effect of self-quenching is negligible in
this analysis. In both cases, partial replacement from
DMAE-ss-PRX to Rho-DMAE-ss-PRX resulted in an
increase of ﬂuorescence intensity peaked at 590nm by
FRET, coupled with a decrease of ﬂuorescence intensity
peaked at 530nm. The ratio of DMAE-ss-PRX to
Rho-DMAE-ss-PRX was optimized where the signals
at donor and acceptor were nearly equally detected
(Figure 3b and c).
Confocal imaging and CIDIQ analysis for quantiﬁcation
of pDNA
The cores, in which FRET occurred between QD545-
labeled pDNA and rhodamine-labeled DMAE-ss-PRX
were encapsulated to the T-MENDs, and then condensa-
tion/decondensation status in nucleus was evaluated using
spectral imaging ﬂuorescence microscopy. Typical spectral
data with a core formed with 16DMAE-ss-PRX plus
Rho-14DMAE-ss-PRX were represented in Figure 4
(a)
(b)( c)
Figure 3. FRET between QD-labeled pDNA and rhodamine-labeled DMAE-ss-PRX. (a) Schematic diagram illustrating the principles of
condensation-dependent FRET occurrence between QD-labeled pDNA and rhodamine-labeled DMAE-ss-PRX. (b and c) Optimized FRET
between QD-labeled pDNA and rhodamine-labeled DMAE-ss-PRX. FRET between QD545 (excitation at 488nm and emission at 545nm) and
rho-DMAE-ss-PRX was monitored by spectrophotometer. For condensation, QD-labeled pDNA was condensed with 16DMAE-ss-PRX containing
Rho-DMAE-ss-PRX (b) and 46DMAE-ss-PRX containing Rho-DMAE-ss-PRX (c) keeping constant N/P ratio at 5.
M (a)( b) N Q Pre Pro Pro MNQ P r e
EtBr(-) EtBr(+)
Free 
QD
QD-
Labeled
pDNA
1234 5678
19.33
7.44
6.22
4.26
3.47
2.69
1.88
1.49
0.93
(kbp)
Figure 2. Conﬁrmation of QD-labeling of pDNA by agarose gel elec-
trophoresis. QD and pDNA was visualized by UV-irradiation before
(a) and after (b) staining with EtBr. M, size marker; lanes 1 and 5,
native pDNA; lanes 2 and 6, QD only; lanes 3 and 7, QD-labeled
pDNA before puriﬁcation; lanes 4 and 8, QD-labeled pDNA after
puriﬁcation. QD ﬂuorescence was detected directly under UV irradi-
ation without EtBr staining (a).
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46DMAE-ss-PRX, respectively).
Some clusters represent single-peaked spectrum at
550nm, which suggest the pDNA in completely
decondensed form. Meanwhile, some clusters represent
maximum peak at 590nm as well as 550nm, which repre-
sents pDNA in condensed form. Fluorescence ranging
from 537 to 569nm (donor ﬂuorescence), and >580nm
(acceptor ﬂuorescence) was separately collected by
LSM510-META equipment, and then digitally exhibited
in green (G) and red (R) channels, respectively (Figure 4b
for 16DMAE-ss-PRX and Figure 4d for 46DMAE-
ss-PRX, respectively). As described above, we conjugated
pDNA with QDs using a molar ratio of 0.4 in this
analysis. Thus, a fraction of the pDNA contains no QD
labeling. However, this has no effect on the following data
analysis, since pDNA, when free from donor (QD), does
not emit ﬂuorescence, either at 537–569nm or at >580nm.
The nucleus was stained with Hoechst33342, and observed
in a blue channel (B).
For the quantiﬁcation of pDNA in condensed form
and decondensed form, confocal image-assisted
three-dimensionally integrated quantiﬁcation (CIDIQ)
method was used which are developed to quantify the
intracellular distribution of pDNA (8,31,33). The
boundaries of red and green clusters were ﬁrst detected
by digitally extracting the pixels above background
levels (Figure 5a). The pixels appearing as green and red
denoting pDNA in the decondensed form (Figure 5a-i),
and the condensed form with (Figure 5a-ii)
DMAE-ss-PRX, respectively. It is noteworthy that the
pDNA detected in the cytoplasmic region (extra-nuclear
regions) are mainly detected as red clusters
(Supplementary Figure S3). Thus, pDNA exists in the
condensed form in the cytoplasm, presumably because
of the protection afforded by the lipid envelope. Pixels
which satisfy red- and green-positive clusters are deﬁned
as yellow, which represents a partially decondensed
pDNA (Figure 5a-iii). Yellow pixels are barely observed
in 16DMAE-ss-PRX, whereas signiﬁcant amounts of pixel
areas were detected in 46DMAE-ss-PRX. Similarly, the
intra-nuclear region was digitally divided into heterochro-
matin and euchromatin region by monitoring the ﬂuores-
cence signals of Hoechst33342 (Figure 5a-iv). The other
(a)( b)
(c)( d)
Figure 4. Optimization and intracellular visualization of FRET between QD-labeled pDNA and rhodamine-labeled DMAE-ss-PRX. (a and c)
Typical spectra of clusters detected in nuclear region obtained after the transfection of T-MEND prepared with 16DMAE-ss-PRX plus rhodamine
labeled DMAE-ss-PRX (a) or 46DMAE-ss-PRX plus rhodamine labeled DMAE-ss-PRX (c) as the relative ﬂuorescence intensity compared to the
maximum intensity observed at  545nm. (a) Blue, yellow and green arrows (left panel) and spectra lines (right panel) indicate the clusters, where
FRET was completely cancelled (right panel). That indicated as red arrow and line represent cluster where FRET was partially cancelled. (c) Green
arrow (left panel) and spectra line (right panel) indicate the clusters, where FRET was completely cancelled (right panel). Those indicated as red and
blue arrows (left panel) and lines (right panel) represent cluster where FRET was partially cancelled. (b and d) Digital acquisition of QD- and
rhodamine-derived signals. The emitted light derived from QD (ranging from 537 to 569nm) and rhodamine (>580nm) were corrected by META
equipment, and then exhibited in green (G) and red (R) channels, respectively. Hoechst33342 signals excited by a 2-photon Maitai laser (780nm)
were captured, and digitally exhibited in blue (B) channel. (b and d) represent a results of 16DMAE-ss-PRX and 46DMAE-ss-PRX, respectively.
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Figure 5. Schematic diagram illustrating the methodology to quantify the distribution and condensation/decondensation efﬁciency of pDNA.
(a) A typical image showing the intracellular trafﬁcking of pDNA transfected by a T-MEND prepared with 16DMAE-ss-PRX. Z-series of
confocal images were captured by the LSM 510 META. The pixels exhibited as green, red and yellow clusters were exhibited as decondensed,
condensed and partially decondensed pDNA. In addition, the heterochromatin region is deﬁned as a region which possessed high ﬂuorescence signals
in B channel. Typical images representing a deﬁnition of clusters which have strong signals in G and R channels were shown in a(i), a(ii), in both G
and R channels shown in a(iii) and in B channel shown in a(iv). (b) The pixel areas under the decondensed form, partially decondensed form and
condensed form in heterochromatin and euchromatin region are separately integrated through all of the Z-series of confocal images, and then
denoted as S
hetero
k and S
hetero
k, respectively (Supplementary Equation), where k is either R or Y or G.
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region. Finally, the pixel areas of red, green and yellow
clusters, in euchromatin and heterochromatin regions
were independently integrated through all of the Z-series
of confocal images, and denoted as S
eu
k and S
hetero
k
(Figure 5b), where k denote the G or R or Y.
First, pixel areas of pDNA in the whole nucleus
were compared between 16DMAE-ss-PRX and
46DMAE-ss-PRX, which reﬂect a total nuclear delivery
of pDNA. 46DMAE-ss-PRX represents higher nuclear
delivery than that of 16DMAE-ss-PRX in average,
which may partially contribute to the higher gene expres-
sion (Figure 6a). Subsequently, fraction of pDNA under
condensed, partially decondensed and decondensed
pDNA was compared in the whole nucleus (Figure 6b).
In 16DMAE-ss-PRX, nearly equal fraction of pDNA
exists as decondensed and condensed form ( 50% in
average). Partially decondensed pDNA represents very
little contribution in total nuclear pDNA. In contrast, in
46DMAE-ss-PRX, decondensed pDNA mainly sheared
the pDNA in the whole nucleus (>70% in average).
Of note, partially decondensed pDNA contributed a
signiﬁcant part ( 12% in average) of pDNA, which is
one of the signiﬁcant characters different form
16DMAE-ss-PRX. The total pixel areas of pDNA as
decondensed form in whole nucleus were plotted in
Figure 6c, which is an index for the nuclear amount of
pDNA in decondensed form. The higher value ( 4-fold)
in 46DMAE-ss-PRX is in good agreement with the signiﬁ-
cantly higher gene expression in 46DMAE-ss-PRX
(Figure 1c).
To provide an insight into the difference in disposition
of pDNA between 16DMAE-ss-PRX and 46DMAE-
ss-PRX, condensation/decondensation conditions in eu-
chromatin and heterochromatin regions were independ-
ently evaluated. As shown in Figure 7a, a considerable
amount of pDNA was distributed to the heterochromatin
and euchromatin regions in 16DMAE-ss-PRX ( 60 and
40%, respectively; black circle, Supplementary Table S1).
However, the condensation/decondensation status of
pDNA was completely different in heterochromatin and
euchromatin. In heterochromatin, the pDNA was mainly
present as the decondensed form, and vice versa in
euchromatin (Supplementary Table S1). As a result,
decondensation efﬁciency in heterochromatin (E
hetero)i s
drastically higher than that in euchromatin (E
eu)(  70
and 25% in average, respectively; Figure 7d). On the
other hand, in 46DMAE-ss-PRX, >70% of pDNA was
distributed to euchromatin region in average (Figure 7b;
black circle). Moreover, the most unique character in
46DMAE-ss-PRX is that major part of pDNA (>70%)
exists as a decondensed form in euchromatin region
(Figure 7b and e). It should be noted here that neither
labeling DNA with QD, nor a polycation with rhodamine,
affects the size and zeta-potentials of particles
(Supplementary Table S2).
(a)( b) (c)
Figure 6. Quantiﬁcation of p-DNA status in whole nucleus. (a) The total pixel area of pDNA calculated as (S
whole
G,+S
whole
R+S
whole
Y), which is an
index of the total accumulation of pDNA in the whole nucleus plotted. (b) Fraction of pDNA in condensed-, decondensed- and partially
decondensed form in whole nucleus. F
whole
k values were calculated as described in ‘Materials and Methods’ section, where k is R, G and Y,
respectively. (c) Total pixel areas of decondensed pDNA in whole nucleus. Total pixel area of pDNA observed as decondensed form in whole
nucleus was calculated as described in ‘Materials and Methods’ section, and plotted. Circles and bars represent calculated values in independent 10
cells and mean values.
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In the present study, we established a method for quan-
tifying the intra-nuclear localization and condensation/
decondensation status of pDNA from a condenser in the
nucleus. We imaged the intra-nuclear FRET, occurring
from donor (QD)-labeled pDNA and acceptor (rhoda-
mine)-labeled DMAE-ss-PRX. Thus, the deﬁnition of
FRET-cancelled signals (green) is the pDNA released
from DMAE-ss-PRX, but it includes pDNA condensed
with other intra-nuclear components. Using this tech-
nique, we found that modulation of the supra-molecular
structure of polyrotaxane affects intra-nuclear disposition.
In our study, we evaluated intra-nuclear disposition at 3h
post-transfection, while transient transgene expression
was examined at 24h post-transfection. Since the metabol-
ic stability of pDNA by DNase digestion is short (half-life;
<1–2h) (34), we assume that the initial-phase of intracel-
lular trafﬁcking and intra-nuclear disposition accurately
(a)
(d) (e)
(b)( c)
Figure 7. Procedures for quantiﬁcation of pDNA under condensed/decondensed form in intra-nuclear subdomains. (a and b) Fraction of pDNA in
condensed-, decondensed- and partially decondensed form in nuclear subdomains. F
hetero
k and F
eu
k values were determined as described in ‘Materials
and Methods’ section after the transfection with 16DMAE-ss-PRX (a) and 46DMAE-ss-PRX (b), where k is R, G and Y, respectively. (c) Total pixel
areas of decondensed pDNA in euchromatin region. S
eu
G values were calculated as described in ‘Materials and Methods’ section, and plotted. Circles
and bars represent calculated values in independent 10 cells and mean values. After the transfection with T-MENDs prepared with 16DMAE-ss-PRX
(d) and 46DMAE-ss-PRX (e), decondensation efﬁciencies of pDNA in whole nucleus (E
whole), heterochromatin (E
hetero) and euchromatin (E
eu) were
plotted. Formulas for calculation of E
whole, E
hetero and E
eu were described in Supplementary Data.
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ence between 16DMAE-ss-PRX and 46DMAE-ss-PRX is
that pDNA cores formed with 16DMAE-ss-PRX were
dominantly decondensed from polycation in heterochro-
matin region (Figure 7a and d), while those prepared with
46DMAE-ss-PRX were preferentially decondensed in eu-
chromatin region (Figure 7b and e).
Since we previously reported that the cleavage of SS
bonds in the capping structure by dithiothreitol is not suf-
ﬁcient for decondensation (35), tentative swelling and
opening-up of the particle structure is not likely. We pre-
viously found that the nuclear transcription efﬁciency of
lipoplex in terms of the ratio of gene expression-positive
cells to nuclear pDNA-positive cells drastically increased
in the late S and G2/M phase (36), when histone mRNA
increases. Replacement with a cationic counterpart such
as a histone might be a possible driving force for
decondensation in DMAE-ss-PRX. Taking the mechan-
ism for the nuclear delivery by a T-MEND into the con-
sideration, the difference in nuclear region-dependent
decondensation properties can be explained by the
nuclear structure and the degree of resistance to
decondensation in a cationic histone-rich environment.
Histological electron microscopic observations of the
nucleus clariﬁed that the nuclear lamina meshwork plays
an important role in controlling nuclear shape, and that a
subset of heterochromatin is located against the inner
surface of the lamina. As a result, heterochromatin
forms a rim around the nucleus and is interrupted by
nuclear pores (37). Therefore, it is plausible that the
nascent polyplexes, introduced by nuclear membrane
fusion ﬁrst pass through the histone-rich heterochromatin
region. Since 16DMAE-ss-PRX has less cationic DMAE
units in one chain compared to 46DMAE-ss-PRX, it may
form a looser complex. It is supported by the fact that
pDNA core formed with 16DMAE-ss-PRX are larger in
size, compared to that prepared with 46DMAE-ss-PRX
(Table 1 and Supplementary Table S2). Thus,
decondensation of pDNA from 16DMAE-ss-PRX may
be extensively triggered in heterochromatin by replace-
ment of counterpart from cationic polymer to basic
histone, enriched in the heterochromatin region. In
contrast, pDNA forms more tightly condensed particle
with 46DMAE-ss-PRX. Therefore, it may be resistant to
the undesired decondensation in heterochromatin region.
It remains to be clariﬁed a driving force of the efﬁcient
euchromatic decondensation in 46DMAE-ss-PRX.
Euchromatin decondensation was subsequently
accelerated by the natural cellular dynamics of transcrip-
tions so that the higher green pixel area was found, which
was consistent with the respective transfection activities
(Figures 1c and 7c).
Meanwhile, the issue of whether heterochromatin/eu-
chromatin localization extends to the next-generation
cell is an important issue to be clariﬁed, since it is
closely linked to the sustained gene expression. However,
the intra-nuclear behavior of pDNA during cell-division is
not completely understood. While some reports showed
that ﬂuorescence-tagged pDNA is excluded from
daughter cells (38), another report showed that pDNAs
tagged with protein nucleic acid (PNA) are evenly
separated between next-generation cells (39). The
question is whether pDNA transfected by a non-viral
vector behaves as chromosomal DNA or extra-
chromosomal DNA remains to be clariﬁed in the future.
The T-MEND was originally developed for use as a gene
carrier for dendritic cells (23). The control of intra-nuclear
disposition may offer more efﬁcient antigen-expression
and presentation in dendritic cells and could be the basis
for practical use in DNA vaccination thereby.
In conclusion, we developed a de novo method for quan-
tifying the decondensation of pDNA in heterochromatin
and euchromatin separately by means of a QD-FRET
technique. Using this system, the ﬁndings show that the
condensation/decondensation efﬁcacy in heterochromatin
and euchromatin can be successfully controlled by
modulating the number of cationic moieties per molecule
of DMAE-ss-PRX, so that a therapeutic gene can be efﬁ-
ciently delivered to the euchromatin sub-domain. QD-
FRET imaging technology is highly advantageous for
clarifying the dynamics of plasmid DNA in post-nuclear
delivery processes.
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